NEW YORK (GenomeWeb) – WaferGen Biosystems has filed with regulators to offer up to $40 million of its common stock.

In its Form S-1 filed recently with the US Securities and Exchange Commission, the company also said that it has applied with the Nasdaq to list its common shares on the Nasdaq Capital Market under ticker symbol "WGBS." The company said that it expects the Nasdaq listing to occur upon consummation of the $40 million offering. WaferGen currently lists its stock on the OTCQB Marketplace.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.